Grant J. Esposito

Grant Esposito focuses his trial and arbitration practice on complex commercial litigation, including health care, securities law, intellectual property, and product liability. He has particular expertise in representing clients in the life sciences and professional-services industries in cross-border matters.

Litigation Approach

Grant works with clients to identify pragmatic and cost-effective solutions to their challenging legal problems, crafting case strategies aligned with their business objectives and needs. Grant sees the big picture and focuses on the key issues at stake, enabling him to position clients for successful outcomes whether during motion practice, at settlement, or at trial. A client noted that Grant “understands from the beginning your strengths and weaknesses and is not afraid to tell you.”

His legal acumen has been recognized by clients and leading publications in the field. He was named an American Lawyer Litigator of the Week, an IP MVP by Law360, and a Trailblazer in Intellectual Property Law by the National Law Journal. Grant has also been recognized in Chambers USA (New York–General Commercial Litigation), Legal 500 US (Litigation–Product Liability, pharmaceuticals and medical devices), Best Lawyers in America (New York–Product Liability Litigation), and New York Super Lawyers (General Litigation).

Representative Experience

• Amgen Inc., et al. v. Sandoz Inc., et al. (N.D.C.A.).
  Secured a victory on behalf of Sandoz Inc. in the first case to interpret the Affordable Care Act’s Biologics Price Competition and Innovation Act (BPCIA). The federal district court ruled in Sandoz’s favor, adopting Sandoz’s interpretation of the BPCIA in all respects. The court also denied Amgen’s motions urging a contrary interpretation and seeking a preliminary injunction.
• Romano et al v. Northrop Grumman et al (E.D.N.Y.)
  Lead trial counsel in $600 million class action alleging environmental contamination and toxic tort claims.
• Mosher v. DaVita Healthcare Partners (N.Y. Com. Div.).
  Represent DaVita in an escrow dispute and related matters arising from Davita’s $4.2 billion acquisition of HealthCare Partners Holdings LLC.
• United Food and Commercial Workers Unions and Employers Midwest Health Benefits Fund et al. v. Novartis Pharmaceuticals Corp., et al. (D. Mass.).
  Represented client in a putative antitrust class action alleging sham litigation arising from settlement of ANDA litigation.
• Confidential Arbitrations.
  Numerous confidential proceedings involving breach of contract, licensing/royalties, payor-provider disputes, and merger-related litigation.

Learn more about Grant’s representative experience.

More About Grant

A chair of Morrison & Foerster’s Litigation Department, Grant advises on litigation management and business development issues. He also counsels Boards of major companies on litigation risk and disclosure issues. In addition, Grant serves as a member of the firm’s Executive and Compensation Committees.

In his spare time, Grant enjoys coaching youth sports (baseball, basketball, and football) and judging High School Speech and Debate tournaments.